Fosrenol (lanthanum carbonate) Chewable Tablets and Oral Powder 

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) February 2016 WARNINGS AND PRECAUTIONS (Revisions) Serious cases of gastrointestinal obstruction, ileus, subileus, gastrointestinal...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts